Published in Hum Genet on May 21, 2016
[Interstitial processes of the lungs in childhood]. Pathologe (2017) 0.75
Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity. PLoS One (2017) 0.75
Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis. Lung (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol (2009) 4.70
New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol (2007) 3.37
Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol (1994) 3.35
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax (2000) 2.49
Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci (2010) 1.87
Mechanisms initiating lung injury in the preterm. Early Hum Dev (1998) 1.76
Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet (2001) 1.43
Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol (2004) 1.29
Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr (2010) 1.29
Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet (2010) 1.26
Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun (2008) 1.06
Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One (2012) 1.04
Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy (2006) 1.03
Modifier genes in cystic fibrosis. Pediatr Pulmonol (2005) 1.03
Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis. BMC Pulm Med (2012) 1.01
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun (2015) 1.01
Testing for concordant equilibria between population samples. Genetics (2000) 0.99
Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr Pulmonol (2008) 0.98
Cystic fibrosis and survival to 40 years: a case-control study. Eur Respir J (2010) 0.94
Haplotypes in the interleukin 8 gene and their association with chronic periodontitis susceptibility. Biochem Genet (2010) 0.94
A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int (2002) 0.93
Validation of new brazilian predicted values for forced spirometry in caucasians and comparison with predicted values obtained using other reference equations. J Bras Pneumol (2007) 0.92
The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. BMC Pulm Med (2012) 0.92
IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. J Immunol (2009) 0.91
Disease modifying genes in cystic fibrosis. J Cyst Fibros (2005) 0.91
Genetic interaction of GSH metabolic pathway genes in cystic fibrosis. BMC Med Genet (2013) 0.90
Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules (2015) 0.88
Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet (2014) 0.88
Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders. Semin Respir Crit Care Med (2015) 0.86
Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk. Croat Med J (2014) 0.85
Association between the IVS4G>T mutation in the TCF7L2 gene and susceptibility to diabetes in cystic fibrosis patients. BMC Res Notes (2012) 0.84
Association between interleukin-8 -251A/T polymorphism and risk of lung cancer: a meta-analysis. Cancer Invest (2014) 0.81
[Bronchopulmonary dysplasia]. J Pediatr (Rio J) (2005) 0.80
Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas. J Mol Diagn (2015) 0.80
Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J Hum Genet (2006) 0.80
Genetic polymorphisms and sepsis in premature neonates. PLoS One (2014) 0.80
Genetic polymorphisms and risk of recurrent wheezing in pediatric age. BMC Pulm Med (2014) 0.79
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease. Gene (2014) 0.79
Polymorphism of the IL-8 gene and the risk of ovarian cancer. Cytokine (2014) 0.79
Polymorphisms in interleukin 8 and its receptors (IL8, IL8RA and IL8RB) and association of common IL8 receptor variants with peripheral blood eosinophil counts. J Hum Genet (2006) 0.79
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. BMC Med Genet (2014) 0.79
Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma. Pediatr Allergy Immunol (2014) 0.78
Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonatal chronic lung disease. Clin Perinatol (2000) 0.78
TNF-alpha polymorphisms as a potential modifier gene in the cystic fibrosis. Int J Mol Epidemiol Genet (2014) 0.77
Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality. Curr Drug Targets (2015) 0.76
A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update. Urol J (2015) 0.75